California’s 800,000 farmworkers have been hit hard by COVID-19, the disease that has infected more than 25 million people and killed more than 420,000 in the United States. Farmworkers are especially vulnerable to the airborne virus that causes COVID-19 because they often live, work and carpool in close quarters with other people. As essential employees, farmworkers have stayed on the job during the pandemic to plant, process and harvest the nation’s food.
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. The work was carried out at the California National Primate Research Center at the University of California, Davis, and is published Jan. 22 in the journal Nature Communications.
The University of California, Davis and InVixa Inc., a biopharmaceutical startup, have executed a licensing agreement for a novel method using inhaled statins to treat the severe respiratory disease known as COVID-19.
The coronavirus vaccine developed by Pfizer Inc. and BioNTech that is being administered worldwide is 95% effective in preventing COVID-19, according to a study published in the New England Journal of Medicine that includes clinical trial data from UC Davis School of Medicine.
Two fast-spreading COVID-19 variants discovered in recent months have health officials concerned worldwide, especially as the pandemic rages worse than ever in many places, including California.
More than half of Latina mothers surveyed in Yolo and Sacramento counties reported making economic cutbacks in response to the pandemic shutdown last spring — saying they bought less food and missed rent payments. Even for mothers who reported receiving the federal stimulus payment during this time, these hardships were not reduced, University of California, Davis, researchers found in a recent study.